ArticleFrontiers in immunology2026

Impact of immune-related adverse events on treatment outcomes in advanced esophageal squamous cell carcinoma treated with immune checkpoint inhibitors.

Tianhang Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.